Colistin resistance in Parisian inpatient faecal Escherichia coli as the result of two distinct evolutionary pathways-Reference-Cited by-同舟云学术

Colistin resistance in Parisian inpatient faecal Escherichia coli as the result of two distinct evolutionary pathways

Published:2019-03-12 Issue:6 Volume:74 Page:1521-1530
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Bourrel Anne Sophie¹,Poirel Laurent²³,Royer Guilhem¹⁴⁵,Darty Mélanie¹,Vuillemin Xavier¹,Kieffer Nicolas²³,Clermont Olivier⁴,Denamur Erick⁴⁶,Nordmann Patrice²³,Decousser Jean-Winoc¹⁴,LAFAURIE Matthieu,BERCOT Béatrice,WALEWSKI Violaine,LESCAT Mathilde,CARBONNELLE Etienne,OUSSER Fateh,IDRI Nadia,RICARD Jean-Damien,LANDRAUD Luce,LE DORZE Mathieu,JACQUIER Hervé,CAMBAU Emmanuelle,LEPEULE Raphaël,GOMART Camille,

Affiliation:

1. Laboratoire de Bactériologie et d’Hygiène Hospitalière, CHU Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France

2. Laboratoire Européen Associé INSERM, Emerging Antibiotic Resistance in Gram-Negative Bacteria, Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland

3. National Reference Centre for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland

4. IAME, UMR1137 INSERM, Université Paris Diderot, Université Paris Nord, Emerging Antibiotic Resistance in Gram-Negative Bacteria, Paris, France

5. LABGeM, Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Univ Evry, Université Paris-Saclay, Evry, France

6. Laboratoire de Génétique Moléculaire, Hôpital Bichat, Assistance Publique - Hôpitaux de Paris, Paris, France

Funder

Laboratoire Européen Associé INSERM

Emerging Antibiotic Resistance in Gram-Negative Bacteria

Swiss National Science Foundation

Assistance Publique - Hôpitaux de Paris

Fondation pour la Recherche Médicale

Publisher

Oxford University Press (OUP)